Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Opioids Agonist Drugs Market 2018, Forecast to 2023

Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.

Scope of the Report:
This report focuses on the Opioids Agonist Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
The worldwide market for Opioids Agonist Drugs is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 23800 million US$ in 2023, from 18600 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone

Market Segment by Applications, can be divided into
Pain Management
Cough Treatment
Diarrhea Treatment

There are 15 Chapters to deeply display the global Opioids Agonist Drugs market.
Chapter 1, to describe Opioids Agonist Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Opioids Agonist Drugs, with sales, revenue, and price of Opioids Agonist Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioids Agonist Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions